Announcement regarding Non-Applicability of Related Party Transaction under Regulation 23(9) of SEBI LODR
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences has informed BSE that the disclosure of related party transactions under Regulation 23(9) of SEBI (LODR) Regulations, 2015 does not apply to it for the quarter and half year ended September 30, 2025. The exemption comes under Regulation 15(2), which covers listed companies whose paid-up equity share capital is below Rs. 10 crore and net worth is below Rs. 25 crore. As on March 31, 2025, the company's paid-up equity capital stood at Rs. 4.00 crore and net worth at around Rs. 4.02 crore, both well within these limits. The company has stated it will begin complying with the disclosure within six months if it crosses these thresholds in the future. The filing is signed by Managing Director Jayendra Mehta.
This is a routine compliance clarification with no operational or financial impact. It simply confirms that the company is small enough (under Rs. 10 crore equity capital and Rs. 25 crore net worth) to be exempt from related party transaction disclosures. No material effect on shareholders or stock price is expected.